Replies to post #202070 on Biotech Values

[dewophile]

This trial has been enrolling for close to a year. They added a nivo + chemo arm as well

https://clinicaltrials.gov/ct2/show/NCT02477826?term=nivolumab+yervoy+lung&rank=2

[DewDiligence]

Next BMY trial [in first-line NSCLC] will be monotherapy, very similar to this MRK trial except with potentially broader PD-L1 cutoff.

You can remove the word, potentially insofar as BMY has confirmed that the expression cut-off will be lower than the 50% used by MRK.